- Home
- INKT vs FLGC Comparison
INKT vs FLGC Comparison
Compare INKT & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- FLGC
- Stock Information
- Founded
- INKT 2017
- FLGC 2019
- Country
- INKT United States
- FLGC United States
- Employees
- INKT N/A
- FLGC N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- FLGC Health Care
- Exchange
- INKT Nasdaq
- FLGC Nasdaq
- Market Cap
- INKT 69.2M
- FLGC 15.9M
- IPO Year
- INKT 2021
- FLGC 2021
- Fundamental
- Price
- INKT $14.24
- FLGC $29.81
- Analyst Decision
- INKT Buy
- FLGC Strong Buy
- Analyst Count
- INKT 3
- FLGC 1
- Target Price
- INKT $37.50
- FLGC $156.00
- AVG Volume (30 Days)
- INKT 45.1K
- FLGC 11.1K
- Earning Date
- INKT 11-13-2025
- FLGC 11-12-2025
- Dividend Yield
- INKT N/A
- FLGC N/A
- EPS Growth
- INKT N/A
- FLGC N/A
- EPS
- INKT N/A
- FLGC N/A
- Revenue
- INKT N/A
- FLGC $52,373,000.00
- Revenue This Year
- INKT N/A
- FLGC N/A
- Revenue Next Year
- INKT N/A
- FLGC $10.22
- P/E Ratio
- INKT N/A
- FLGC N/A
- Revenue Growth
- INKT N/A
- FLGC N/A
- 52 Week Low
- INKT $4.56
- FLGC $15.15
- 52 Week High
- INKT $76.00
- FLGC $82.29
- Technical
- Relative Strength Index (RSI)
- INKT 47.11
- FLGC 69.41
- Support Level
- INKT $13.11
- FLGC $22.00
- Resistance Level
- INKT $16.20
- FLGC $23.59
- Average True Range (ATR)
- INKT 1.13
- FLGC 1.67
- MACD
- INKT -0.01
- FLGC 0.84
- Stochastic Oscillator
- INKT 35.38
- FLGC 78.23
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.